Conference abstractPublished 2021

A natural solvent improves β-lactam antibiotic efficacy

Authors: Belen Olivares

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Statement of the Problem: World Health Organization declared bacterial infections by resistant pathogens a global crisis and place it among its priority lines of research. The aim of the present work is to improve the antibacterial efficacy of available molecules. We focus on beta-lactam antibiotics, a very useful therapeutic class of antibiotics, but unstable in the aqueous solvents of conventional formulations. That condition represents a clinical problem leading to therapeutic failure and antimicrobial resistance. We designed a new vehicle based on a natural deep eutectic solvent consisting on betaine and urea (BU). BU is capable of improving the stability of some beta-lactams including imipenem (IMP) the most unstable of the beta-lactam family. The main goal of the present work is to evaluate the therapeutic efficacy, the kinetics of IMP release, and the in vitro toxicological profile of the new solvent. Methodology: Killing curves of Pseudomonas aeruginosa incubated at 37°C, with IMP dissolved in BU in comparison with its aqueous solutions. Viability measures were made counting bacteria by flow cytometry using SytoBC®/ propidium iodide. The kinetic of IMP release was evaluated using a diffusional test based on a bicameral devise model. Data were analyzed applying Peppas Krosmayer equation. Cytotoxicity was evaluated using primary fibroblasts cultures. Findings: IMP-BU reduced the P. aeruginosa flow cytometry counting forty times compared to IMP aqueous solution (mean and SEM 1,87x107 ±3,91x 106 and 7,5x108 ± 3x107 respectively) in 24 hours. The value of the diffusional coefficient obtained (n=1,01) indicates a case II release, consisting in a linear and progressive kinetics. Finally, the cytotoxicity assay of BU showed an IC50 of 59,4 mg/ml, higher than the reported for others solvents of this class. Conclusion: BU could represent a new biosafe natural alternative excipient to maintain IMP stability and therefore improve its efficacy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in International Journal of Drug Development and Research.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Journal of Drug Development and Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Belen Olivares”